"The vast majority of diseases or brain issues, I think are fixable with a Neuralink device."Elon Muskhttps://t.co/FVCBNaPAV5 ...

But this right here is really going to bring it home for Ethereum holders and all pretty much altcoin holders moving forward. So what I'm talking about is there's a great interview and this is the CEO of Bit Digital. This is uh Santaar and he's going to say and it it's it's amazing to me.They had a very successful Bitcoin mining company. They got they stopped all Bitcoin mining. They sold all their Bitcoin.They raised funds for Ethereum. And now they hold over a quarter of a billion dollars in Ethereum. Let ...

Today, President Trump's media and technology group files to list a new crypto ETF. Robin Hood CEO Vlad Tennviv defends the company's Open AI and SpaceX stock tokens. And Elliot Chun of Architect Partners discusses the recent wave of crypto M&A activity.Welcome to CNBC's Crypto World. I'm Pelia Kaplan. Crypto prices are mixed along with stocks after President Trump offered no exceptions to his August 1 tariff start date.As of noon Eastern, Bitcoin traded flat, still holding on to the $18,000 level. Aether r ...

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July 8, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced the half-year report of the liquidity contract with Crédit Industriel et Commercial. Under the liquidity contract GENFIT has with Crédit Industriel et Commercial, the following resources appeared on the liquidity account as of June 30, 2025: 201 ...

Core Insights - Rhythm Pharmaceuticals is set to disclose topline results from a Phase 2 trial evaluating bivamelagon for acquired hypothalamic obesity on July 9, 2025 [1][2] Company Overview - Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company focused on rare neuroendocrine diseases [4] - The company's lead asset, IMCIVREE® (setmelanotide), is approved for treating obesity related to specific genetic conditions [4][5] - Rhythm is advancing a clinical development program for setmelanotide and other investigational MC4R agonists, including bivamelagon and RM-718 [4] Bivamelagon Phase 2 Trial Details - The Phase 2 trial is a randomized, placebo-controlled, double-blind study involving 28 patients aged 12 and older [3] - Patients received daily oral doses of bivamelagon (200 mg, 400 mg, or 600 mg) or placebo for 14 weeks [3] - The primary endpoint is the change in body mass index after 14 weeks of treatment, with an option for patients to continue therapy for up to 52 weeks [3]

RT mariaa.eth 🐸 (@MariaShen)5/To meet this demand for truly global financial services, a system must be:– Accessible globally (no geographic gatekeeping)– Safe for institutions (security + regulatory clarity)– Resistant to gov't interferenceEthereum delivers all three. https://t.co/z2hNWaejiD ...

Is now the worst—or best—time to launch a business in a struggling industry? This week on The Big Idea with Elizabeth Gore, chef & Valette Wines owner Dustin Valette joins the show to answer the question: How do you build a business in a struggling industry? Valette shares his family’s story of immigrating to the United States during the early 1900s, settling in Sonoma County, and how that ultimately inspired him to become a restaurateur and owner of a winery. He and Gore discuss the current struggles facin ...

How possible do you think it is to look inside and deeply understand a large language model on the scale from hopeless we can't ever understand it it's just a black box too many neurons to we can actually map out the mind of a neural net I'm curious where you think the field will be I'm very biased but I think it's very very possible a lot of the people in in mechan like come from backgrounds in computational neuroscience or like cognitive science and those people when you're actually looking inside the bra ...

SharpLink Gaming Stock Soars as Ethereum Treasury Firm Boosts Stash to $527 Million► https://t.co/OLJtddLqUM https://t.co/OLJtddLqUM ...

Trump Media and Technology Group is looking to launch another Truth Social-branded crypto ETF for Bitcoin, Ethereum, XRP, Solana, and Cronos. https://t.co/JA8e7BsVnT ...